01—Abstract
Summary
Summary of the 8-K filed November 18, 2025. Cited figures are marked; the original filing is the authoritative source.
Tenet Healthcare Corporation issued two series of notes on November 18, 2025: $1,500,000,000a in aggregate principal amount of 5.500% senior secured first lien notes due 2032 and $750,000,000 in aggregate principal amount of 6.000% senior notes due 2033.
The notes were issued under an indenture dated November 6, 2001 with The Bank of New York Mellon Trust Company, N.A., as successor trustee, as supplemented by the forty-first and forty-second supplemental indentures, each dated November 18, 2025. Tenet intends to use the net proceeds, after fees and expenses, together with cash on hand, to redeem all $1.5 billionb outstanding of its 6.250% senior secured second lien notes due February 2027 and to partially redeem $0.75 billion outstanding of its 6.125% senior notes due October 2028. The filing states that the notes may be redeemed at Tenet's option before November 15, 2028 at 100% of principal plus a make-whole premium, and on or after that date at specified redemption prices, and that the notes may also be subject to redemption upon a change of control.
The First Lien Notes indenture restricts liens, subsidiary guarantees, asset sales, sale and lease-back transactions, and certain consolidations or mergers. The Senior Notes indenture restricts liens, sale and lease-back transactions, and certain consolidations or mergers. The filing notes that these covenants carry important exceptions and that there are no restrictions on incurring additional indebtedness, making restricted payments or dividends, entering into affiliate transactions, or making investments.
02—Key points
Key Highlights
- Tenet issued $1.5 billion of 5.500% senior secured first lien notes due 2032 and $750 million of 6.000% senior notes due 2033 on November 18, 2025.
- Net proceeds, together with cash on hand, are intended to fund the full redemption of $1.5 billion of 6.250% second lien notes due February 2027.
- Tenet also intends to partially redeem $0.75 billion of its 6.125% senior notes due October 2028 with the proceeds.
- The First Lien Notes carry covenants restricting liens, subsidiary guarantees, asset sales, sale and lease-back transactions, and certain mergers or asset sales of substantially all assets.
- The Senior Notes carry narrower covenants restricting liens, sale and lease-back transactions, and certain mergers or asset sales of substantially all assets.
- The indentures place no restrictions on additional indebtedness, restricted payments, dividends, share repurchases, affiliate transactions, or investments.
- Before November 15, 2028, Tenet may redeem either series at 100% of principal plus a make-whole premium; thereafter, at specified redemption prices.
03—Questions
Frequently Asked Questions
What debt did Tenet issue in this transaction?
Tenet issued $1,500,000,000 in aggregate principal amount of 5.500% senior secured first lien notes due 2032 and $750,000,000 in aggregate principal amount of 6.000% senior notes due 2033.
How will Tenet use the proceeds?
The filing states Tenet intends to use the net proceeds, after fees and expenses, together with cash on hand, to redeem all $1.5 billion of its 6.250% senior secured second lien notes due February 2027 and to partially redeem $0.75 billion of its 6.125% senior notes due October 2028.
Do the new notes restrict Tenet from taking on more debt?
No. The filing states that there are no restrictions on Tenet or its subsidiaries incurring additional indebtedness, making restricted payments, paying dividends, purchasing or redeeming capital stock, or entering into affiliate transactions and investments, although the lien, asset sale, and merger covenants do apply.
When can Tenet redeem the new notes?
Before November 15, 2028, Tenet may redeem the notes at its option at 100% of principal plus a make-whole premium, plus accrued and unpaid interest. On and after November 15, 2028, Tenet may redeem them at specified redemption prices set out in the indentures, plus accrued and unpaid interest. Both series may also be subject to redemption upon a change of control.
Where can investors find the full terms of the notes?
The summary is qualified by the base indenture and the forty-first and forty-second supplemental indentures, which are filed as Exhibits 4.1, 4.2 and 4.3 to the report and incorporated by reference.
04—Continue